经阴道无张力尿道悬吊术治疗女性压力性尿失禁40例分析

目的：观察经阴道无张力尿道悬吊术(TVT)治疗女性压力性尿失禁的临床疗效。方法：2001年10月至2003年1月采用经阴道无张力尿道悬吊术治疗40例女性压力性尿失禁。结果：40例手术后尿失禁均得到控制，经随访2—26个月无一例出现尿失禁现象。平均手术时间54min，平均出血量80mL。40例患者恢复正常排尿后到残余尿均＜50mL。结论：TVT手术治疗女性压力性尿失禁具有手术创伤小、在局麻下手术、吊带悬吊效果可靠、作用持久、手术悬吊适度、手术并发症发生率低等优点，适宜临床推广应用。     

经阴道无张力尿道悬吊术治疗女性压力性尿失禁

目的观察经阴道无张力尿道悬吊术治疗女性压力性尿失禁临床疗效。方法采用经阴道无张力尿道悬吊术治疗21例女性压力性尿失禁患者。结果21例患者手术后尿失禁均得到控制,平均手术时间56min,平均出血78 ml,21例患者恢复正常排尿后测残余尿均<50 ml,经随访2-18个月无一例出现尿失禁现象。结论 TVT手术治疗女性压力性尿失禁具有可局麻下手术、手术创伤小、悬吊适度、疗效可靠持久、手术并发症发生率低等优点。适宜临床推广应用。     

自制网片经阴道无张力尿道中段悬吊治疗女性压力性尿失禁

<正>女性压力性尿失禁是中老年妇女的常见病,发病率为15%～30%,成年女性发生尿失禁达46.5%,其中,压力性尿失禁占59.6%。近年治疗压力性尿失禁的新方法不断出现,但疗效较好、并发症少、费用低的方法应推经阴道尿道中段补片悬吊术(童式前路悬吊术),此后童晓文教授对此术进行了改良,将原来网片缝于耻骨降支的骨膜改为经闭孔固定于耻骨降支。2005年12月至2006年12月我们应用此法治疗女性压力性尿失禁30例,现报道如下。     

阔筋膜悬吊术用于治疗女性压力性尿失禁

目的探讨自体阔筋膜吊带行尿道悬吊术治疗女性压力性尿失禁的疗效和安全性。方法对13例压力性尿失禁伴子宫脱垂及阴道前后壁膨出的患者,取自体大腿外侧阔筋膜条作为吊带,经下腹阴道联合切口,行尿道近端悬吊术,同时行阴式全子宫切除及阴道前后壁修补术,平均随访30个月。结果13例患者均获得治愈,无阴道出血、感染、排斥反应等并发症发生。5例患者在术后出现轻度、暂时性排尿困难,1个月内症状消失。结论自体阔筋膜吊带行尿道悬吊术是治疗女性压力性尿失禁的安全有效术式。     

无张力阴道吊带术在女性尿失禁中的应用

目前 ,对于女性压力性尿失禁常用的手术方法主要有耻骨后尿道悬吊术 (Ｂｕｒｃｈｃｏｌｐｏｓｕｓｐｅｎｓｉｏｎ和Ｍａｒｓｈａｌｌ Ｍａｒｃｈｅｔｔｉ Ｋｒａｎｔｚｐｒｏｃｅｄｕｒｅ)、阴道前壁修补术和针穿线吊术 (Ｓｔａｍｅｙ)等 ,均不同程度地存在着较多的远期复发和术后排尿困难等缺点[1 ] 。我科自 1999年 11月以来 ,采用无张力阴道吊带(ｔｅｎｓｉｏｎ ｆｒｅｅｖａｇｉｎａｌｔａｐｅ ,ＴＶＴ)手术治疗 19例女性尿失禁 ,取得良好效果。一、临床资料1.研究对象 :为 1999年 10月至 2 0 0 1年 10月在我科诊治的 19例女性尿失禁患…     

经阴道尿道中段补片悬吊术治疗压力性尿失禁的临床观察

目的评价经阴道尿道中段补片悬吊术治疗压力性尿失禁(SUI)的近期疗效。方法2003年7月—2004年2月,对确诊为SUI的82例患者,在局部麻醉下行经阴道尿道中段补片悬吊术,并于治疗后1、3、6个月进行随访。根据患者的主诉,以能自控排尿、无尿失禁症状为治愈;尿失禁次数及漏尿情况较术前明显减少为改善;尿失禁症状未改善或加重为无效,观察疗效及并发症。结果82例患者平均手术时间(27±9)min,平均出血量(21±6)ml。72例术后2h去除导尿管后能自行排尿,24h后测量残余尿<100ml,术后48h出院;10例术后2h去除导尿管后出现短暂尿潴留,再次留置导尿管48h后排尿正常,再观察24h后出院。82例患者出院时78例为治愈,4例(合并脑出血后遗症患者)为改善。76例随访1~6个月,其中74例为治愈,2例为改善。无发生尿潴留、尿路感染及膀胱功能障碍者。结论经阴道尿道中段补片悬吊术治疗SUI方法简单、近期效果确切。     

单切口经阴道无张力尿道中段悬吊带术TVT-Secur治疗女性压力性尿失禁前瞻性研究

目的:评估单切口经阴道无张力尿道中段悬吊带术(TVT-Secur)治疗女性压力性尿失禁术后2年的疗效。方法:对经尿动力学检查证实为压力性尿失禁同时伴有不同程度的阴道后壁膨出的21例患者,行单切口经阴道无张力尿道中段悬吊带术及阴道后壁修补术治疗,记录围手术参数、疼痛评分及并发症,并随访了术后2年内的临床效果。结果:实行TVT-Secur手术的21例患者均在静脉麻醉下完成;平均手术时间9.7min;平均术中出血量36.9ml;患者均在术后24h内自行排尿,19例(91%)残余尿为0,2例(9%)残余尿<50ml。术后视觉模拟疼痛评分(VAS)均<3分,平均1.86分。术中有3例发生阴道壁穿透,无术后并发症及术后病率。术后以患者主观感觉和客观尿垫试验为评价标准,平均随访17.3个月,主观治愈率95.2%(20/21),客观治愈率85.7%(18/21),改善率9.5%(2/21)。结论:单切口经阴道无张力尿道中段悬吊带术是治疗女性压力性尿失禁微创、低疼痛和安全的手术方法,近期疗效满意。     

经阴道无张力尿道悬吊术治疗尿失禁22例临床分析

目的:探讨经阴道无张力尿道悬吊术(tension free vaginal tape,TVT)治疗尿失禁的临床价值。方法:对22例压力性尿失禁患者采用TVT手术,观察手术时间、术中出血量、术中损伤、术后体温、术后病率及术后排尿情况。结果:22例患者手术时间为30~88分钟,平均49.77±21.29分钟。术中出血15~50 ml,平均31.75±13.46 ml。22例患者术后体温均未超过38℃,无术后病率发生。术后留置尿管1~7天拔管,3例出现排尿困难,留置尿管10天后排尿恢复,无一例出现膀胱损伤、耻骨后血肿、血管损伤和切口部位感染。结论:TVT手术治疗压力性尿失禁具有手术创伤小、快捷、出血少、术后留置尿管和留院时间短、恢复快的优点,适合临床推广应用。     

阴道无张力尿道中段悬吊术治疗压力性尿失禁临床效果分析

目的　探讨阴道无张力尿道中段悬吊术(TVT)治疗女性压力性尿失禁的临床结局。方法　2001年 1月至 2003年 12月北京协和医院对 60例经尿动力学证实为压力性尿失禁 (其中 4例为混合性尿失禁)同时伴有不同程度盆底器官膨出患者进行了TVT术及相关妇科手术,采用标准化前瞻、开放研究对术前、后进行评估。结果　单行TVT平均手术时间 27 52min,术中出血量平均为 26.12mL,平均住院天数 1 86d。未发生术中严重并发症, 16.7%患者发生尿潴留的近期并发症;患者年龄≥ 50岁组比 <50岁组易发生尿潴留 (P<0 01 ); 2例(3.3% )发生远期并发症;其他妇科手术与TVT术同时进行无术后病率的发生;以患者主观感觉评价,平均随诊12.38个月, 96.7%患者治愈, 3.3%主观改善明显,无一例无效,随访未见患者有复发的征兆。结论　TVT术是治疗女性压力性尿失禁的一种微创、安全和有效的手术方法。其他妇科手术与TVT术同时操作是可行的。     

Grouts-Blaivas评分法评价无张力阴道吊带术治疗压力性尿失禁的临床价值

目的:观察无张力阴道吊带术(TVT)治疗女性压力性尿失禁的临床疗效,并探讨Grouts-Blaivas评分法评价该法治疗尿失禁效果的临床价值。方法:对25例中、重度女性压力性尿失禁患者采用TVT治疗,手术后采用Grouts-Blaivas评分法评价尿失禁情况,并定期随访。结果:25例患者TVT均取得满意疗效。术后随访3~21个月,按Grouts-Blaivas评分法,尿失禁治愈率为92%(23/25),1例改善良好,1例改善中等,无手术失败及严重并发症发生。结论:TVT治疗女性压力性尿失禁有效、安全,且疗效持久。Grouts-Blaivas评分法是一种较为全面的评价尿失禁疗效的方法。     

A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization

OBJECTIVE: The purpose of this study was to determine if antibiotic prophylaxis with nitrofurantoin monohydrate macrocrystals (study drug) after pelvic organ prolapse and/or urinary incontinence surgery with suprapubic catheterization (SPC) decreases urinary tract infection (uti) compared with placebo in a randomized, double-blind, multicenter trial. STUDY DESIGN: Six centers participated in this study. After a negative preoperative urine culture, history, surgical and postoperative course, urine culture and symptoms at SPC removal, and at 6 to 8 weeks postoperative, any other UTI and adherence were recorded. To demonstrate a 50% decrease in the bacteruria rate from 20%, with 80% power and alpha of 0.05, 438 patients were required. Data were evaluated with Student t test and Fisher exact test. RESULTS: Of 449 patients enrolled, 211 randomized to study drug, and 224 randomized to placebo. No pre- or perioperative differences existed between groups (all P>.05). Antibiotic prophylaxis decreased positive urine cultures compared with placebo (46% vs 61%, P=.002), symptomatic UTI at SPC removal (7.2% vs 19.8%, P=.001), and any other symptomatic UTI 6 to 8 weeks postoperatively (18.9% vs 32.6%, P=.002). Antibiotic prophylaxis did not decrease symptomatic UTI at the 6- to 8-week postoperative visit (1.8% vs 5.4%, P=.10). CONCLUSION: Antibiotic prophylaxis with nitrofurantoin monohydrate macrocrystals decreases UTI compared with placebo after pelvic organ prolapse and/or urinary incontinence surgery with suprapubic catheterization.     

Long-term results of tension-free vaginal tape (TVT) for the treatment of female urinary stress incontinence

OBJECTIVES: Prospective evaluation of outcome and complications over a 5-year period post-treatment of urinary stress incontinence by TVT, and comparison of our results with the reference studies. MATERIALS AND METHODS: About 94 patients were treated for urinary stress incontinence only by one TVT procedure (single surgical procedure), between April 1997 and December 1998; 68% of patients presented pure urinary stress incontinence and 32% mixed incontinence. We found also a 25.5% rate of sphincter deficiency (UCP < 20 cm H(2)O) in this cohort. Patients were evaluated after 5 years: 52 complete evaluations (clinical, flow measurement with measurement of post-mictional residue, 24h PAD-test, quality of life questionnaire), 30 complete telephone interviews, 12 lost to follow-up (2 patients deceased). RESULTS: About 87% of the patients had a 5-year follow-up. The success rate was 79.2% overall (84.5% for the pure urinary stress incontinence and 67% for the mixed incontinence cases), and 72.2% for the cases of associated sphincter deficiency. We had only a 13% rate of patients lost to follow-up. More than half of the urinary urgency cases were treated successfully, however with a less satisfactory outcome in cases of bladder instability. The urodynamic exploration appeared to reveal that TVT caused dysuria: 52% of patients had a maximum flowrate below 15 ml/s, but the quality of life was improved, with a 95% rate of satisfaction without functional problems. We observed no late complications such as vaginal erosion or rejection of the prolene; the de novo syndrome was rare, with 8.5% of urinary frequency, 6% of urinary urgency and only 5.7% of invalidating dysuria. We saw no cases of pelvic floor disease after TVT treatment. DISCUSSION: Our casuistry results are comparable with the reference studies by Scandinavian authors, Rezapour and Ulmsten, confirming the long-term success of the TVT procedure. Concerning the apparently elevated rates of post-TVT dysuria found by urodynamic exploration, a distinction has to be drawn between post-TVT urinary problems (frequent but oligosymptomatic), and true, severe dysuria (rare). However, "dysuria" in the broad sense did not affect the patients' quality of life, and is a reminder of the absolute necessity of meticulous compliance with the correct surgical techniques. CONCLUSION: Treatment of urinary incontinence by TVT is a reliable, mini-invasive, reproducible technique, almost suitable for outpatients, with no serious complications; it is inexpensive and very successful, including in complicated cases such as sphincter deficiency. All the recent data confirms, with this 5-year follow-up, that the TVT procedure is comparable to the previously gold standard, the Burch colposuspension.     

Delayed positioning of multifilament tape (IVS transobturator tape) in treatment of stress urinary incontinence caused by the radiotherapy

Radiotherapy is used to treat advanced stages of cervical cancer. Despite optimization of the doses delivered during radiotherapy chronic urinary tract complications still occur in 1-5% of patients. We report a case of 60 years old woman, treated 10 years ago for stage III cervical carcinoma. She received both intracavitary brachytherapy and external teletherapy. Since irradiation patient suffered from the stress urinary incontinence (SUI). She was diagnosed in our department and underwent successful anti-incontinence surgery. Because of oncological history and urodynamic parameters (markedly lowered closing urethral pressure) she was assigned to intravaginal slingplasty transobturator (IVS-OT) procedure with delayed positioning of the tape. There were no intra- or postoperative complication. The check-up done four months following surgery revealed that patient have full control of micturition and markedly improved quality of life.     

Surgical management of urinary stress incontinence in women: A historical and clinical overview

Urinary incontinence is a highly prevalent condition that has a significant impact on the affected patients’ quality of life. Approximately one in three women suffers from some degree of urinary incontinence. Six to ten percent of them are severely affected. Cure or significant improvement can often be achieved after making the right diagnosis, tailoring the treatment accordingly and realistically counseling the patient on the expected outcome.